Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ISRCTN12411737) titled 'Investigating the use of obafistat on metabolic health in women with polycystic ovary syndrome' on Sept. 21.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Single
Purpose: Safety
Primary Sponsor: Imperial College London
Condition:
Polycystic ovary syndrome
Nutritional, Metabolic, Endocrine
Intervention:
The AKROPAT trial is a placebo-controlled randomised dose escalation study whereby we aim to treat 44 women with polyendocrine metabolic ovarian syndrome (previously known as polycystic ovary syndrome [PCOS]) with...